Sign In
Buy ABBV
$227.23
+2.30 (+1.02%)
At Close: Jun 05, 2026
AbbVie (ABBV) Beats Stock Market Upswing: What Investors Need to Know
06:51pm, Friday, 01'st Mar 2024
In the most recent trading session, AbbVie (ABBV) closed at $178.91, indicating a +1.62% shift from the previous trading day.
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
10:06am, Friday, 01'st Mar 2024
AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Blue-Chip Backbone: 3 Stocks for Unwavering Market Strength
05:50pm, Thursday, 29'th Feb 2024
It's often said that patience is a virtue for investors that often means taking advantage of the stability of blue-chip stocks. However, that virtue can be sorely lacking among investors.
Better Dividend Growth Stock: AbbVie or Amgen?
09:45am, Thursday, 29'th Feb 2024
Dividend growth stocks have consistently outshined most other asset classes over the past 124 years. AbbVie and Amgen are two of the brightest stars within the healthcare dividend growth stock landsca
OSE Immunotherapeutics to Host a Live Webcast to Discuss AbbVie Global Partnership
01:45am, Wednesday, 28'th Feb 2024
NANTES, France--(BUSINESS WIRE)--OSE Immunotherapeutics to Host a Live Webcast to Discuss AbbVie Global Partnership.
AbbVie Sees More Than $80 Billion Demand for Bond Sale
02:42pm, Thursday, 22'nd Feb 2024
AbbVie is selling around $15 billion of bonds in the US investment-grade market to help fund its acquisitions of ImmunoGen and Cerevel Therapeutics Holdings. Olivia Raimonde has more.
Is AbbVie Stock a Buy Now?
05:15am, Thursday, 22'nd Feb 2024
AbbVie is poised for growth just a couple of years after losing patent protection on its top-selling drug. Emerging products Skyrizi and Rinvoq have exceeded expectations.
AbbVie (ABBV) is a Top Dividend Stock Right Now: Should You Buy?
12:46pm, Wednesday, 21'st Feb 2024
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes?
AbbVie (ABBV) Announces Appointment of New CEO Robert Michael
11:46am, Wednesday, 21'st Feb 2024
Robert Michael is set to succeed Richard A. Gonzalez as AbbVie's (ABBV) CEO, effective Jul 1, 2024.
AbbVie taps new CEO as it faces fresh competition for blockbuster drug Humira
10:46am, Tuesday, 20'th Feb 2024
AbbVie Inc.'s founding CEO Richard Gonzalez will step down July 1, the drugmaker said Tuesday, and will be replaced by the company's current president and chief operating officer, Robert Michael.
AbbVie Names New CEO. The Stock's Not Moving.
10:18am, Tuesday, 20'th Feb 2024
Drug maker AbbVie named current President and Chief Operating Officer Robert Michael to succeed Richard Gonzalez as CEO, effective July 1.
AbbVie taps longtime executive Robert Michael as new CEO, succeeding Richard Gonzalez
10:06am, Tuesday, 20'th Feb 2024
Michael, who is AbbVie's chief operating officer, will become the company's second-ever CEO since the company spun out from Abbott Laboratories in 2013.
AbbVie says Richard Gonzalez to step down as CEO
09:28am, Tuesday, 20'th Feb 2024
AbbVie said on Tuesday that Richard Gonzalez will step down from his role as chief executive officer of the drugmaker on July 1.
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It
10:06am, Monday, 19'th Feb 2024
Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.
3 Cash Cows to Boost Your Confidence During the February Chill
03:20pm, Sunday, 18'th Feb 2024
What are cash cow stocks? If “Jeopardy!
